WebLEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call and webcast at 8:00 a.m. ET Thursday, January 7, 2024, to discuss top-line symptom, redness, and Schirmer’s test results from the run-in cohort of the Phase 3 TRANQUILITY clinical trial in patients with dry eye disease. The … WebNov 16, 2012 · Dr. Alexander A Axelrod accepts Medicare-approved amount as payment in full. Contact Dr. Alexander A Axelrod at 7373 S France Ave to request Dr. Alexander A …
Aldeyra Therapeutics Stock (NASDAQ:ALDX), Analyst Ratings, …
WebThe latest price target for Aldeyra Therapeutics ( NASDAQ: ALDX) was reported by HC Wainwright & Co. on Friday, March 10, 2024. The analyst firm set a price target for 15.00 expecting ALDX to rise ... WebApr 10, 2024 · A high-level overview of Aldeyra Therapeutics, Inc. (ALDX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. rcf tt 10 a
Aldeyra Therapeutics, Inc. (ALDX) - Stock Analysis
WebSee the company profile for Aldeyra Therapeutics, Inc. (ALDX) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives ... WebApr 12, 2024 · Aldeyra Therapeutics, Inc (NASDAQ:ALDX) issued its quarterly earnings results on Wednesday, October, 27th. The biotechnology company reported ($0.27) … WebApr 7, 2024 · Company Profile ALDX Business Description Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation … rcf tts 18